This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Poised for Breakouts

Alexion Pharmaceuticals

Another name in the biotechnology and drugs complex that looks ready to trigger a major breakout trade is Alexion Pharmaceuticals (ALXN - Get Report), which is focused on serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. This stock is off to a decent start in 2012, with shares up around 30%.

If you look at the chart for Alexion Pharmaceuticals, you'll see that this stock has been uptrending strong for most of 2012, with shares skyrocketing from a low of $62.50 to a high of $95.01 a share. That uptrend was briefly broken earlier this month when shares of Alexion moved back below its 50-day moving average of $90.04 a share, and traded to a recent low of $81.28 a share. Following that move, this stock was able to find buying interest around $81.28 to $82.95 a share, and since then it has moved back above its 50-day moving average. Now this stock is quickly pushing within range of triggering a major breakout trade.

Market players should now look for long-biased trades if ALXN can manage to take out some near-term overhead resistance at $94.36 to $95.01 a share with high volume. Look for a sustained move or close above those levels with volume that's near or above its three-month average action of 1.7 million shares. If we get that action soon, then look ALXN to easily trade north of $100 a share in the near future.

On Thursday, over 24.4 million shares traded as ALXN closed up 2.5% to $93.10 a share. And just this morning, news has broken that ALXN has priced a public offering of 5 million shares of common stock at a price to the public of $93.02 a share. The net proceeds to Alexion, after deducting the underwriting discount and other estimated expenses, are expected to be around $462 million.
4 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
ALXN $142.28 0.00%
INFI $5.72 0.00%
MNST $123.73 0.00%
SAIA $25.46 0.00%
YOKU $27.32 0.00%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs